In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and endocrine diseases. For more information, visit deepappletx.com.
Company Details
- Employees
- 32
- Founded
- -
- Address
- San Francisco Bay Area, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://deepappletx.com
- Keywords
- drug discovery, deep learning, AI, large-scale docking, structural biology, machine learning, drug development, biotechnology.
- HQ
- San Francisco Bay Area
Deep Apple Therapeutics Questions
Deep Apple Therapeutics's website is http://deepappletx.com
Deep Apple Therapeutics's LinkedIn profile is https://www.linkedin.com/company/deep-apple-therapeutics
Deep Apple Therapeutics has
32 employees.
View email and phone details for 32
employees at Deep Apple Therapeutics.
Deep Apple Therapeutics's industry is
Biotechnology Research
Deep Apple Therapeutics's top competitors are
Rezo Therapeutics,
Nine Square Therapeutics,
Novo Nordisk,
Maze Therapeutics,
Atp (Apple Tree Partners),
Septerna,
Initial Therapeutics,
Ascidian Therapeutics,
Evercrisp Biosciences,
Apertor Pharmaceuticals.
Deep Apple Therapeutics's categories are Biotechnology Research
Deep Apple Therapeutics's founding year is 2022
